Tag: Chemotherapy
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
TAR-200 monotherapy was well tolerated, with high complete response rate and prolonged disease-free survival
Public Believes Dermatologic Side Effects From Cancer Treatment Are Common
Findings seen among both those previously treated for cancer and cancer-naive people
Few With Myelodysplastic Syndromes Receive Hypomethylating Agents
Odds of receiving HMAs lower for those 85 years and older, women, Black patients
Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer
Better posttreatment pathology and similar overall survival seen for stereotactic ablative radiotherapy group despite more advanced disease
Updated Recommendations Issued for Management of Grade 4 Diffuse Glioma
Recommendations focus on radiation therapy and/or adjunctive therapies for WHO grade 4 adult-type diffuse glioma
Childhood Cancer Treatment, Genetics Contribute to Subsequent Neoplasm Risk
Contributions quantified for subsequent neoplasms in childhood cancer survivors
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer
Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
Nodal Irradiation Does Not Reduce Recurrence, Death for ypN0 Breast Cancer
No reduction seen in risk with adjuvant regional nodal irradiation among patients with node-positive breast cancer who reached ypN0 status after neoadjuvant chemo
ASCO: Disease-Free Survival Prolonged With Exercise Program in Colon Cancer
Improved survival seen with structured program in patients with resected colon cancer who have completed adjuvant chemo
ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC
Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations
